Par Pharmaceutical, Inc.
11
James L. Garrity Jr.
08/16/2022
08/20/2024
Yes
v
| MEGANY, MEGA, JtAdm, CLMAGT, SchedF |
Assigned to: Judge James L. Garrity Jr. Chapter 11 Voluntary Asset |
|
Debtor Par Pharmaceutical, Inc.
6 Ram Ridge Road Chestnut Ridge, NY 10977 ROCKLAND-NY Tax ID / EIN: 22-2228342 aka Par Pharmaceutical, LLC aka PPI Merger Sub, Inc. |
represented by |
Paul D. Leake
Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, NY 10001 212-735-3000 Fax : 212-735-2000 Email: paul.leake@skadden.com Kyle J. Ortiz
Togut, Segal & Segal LLP One Penn Plaza Suite 3335 New York, NY 10119 212-594-5000 Fax : 212-967-4258 Email: kortiz@teamtogut.com |
U.S. Trustee United States Trustee
Office of the United States Trustee - NY Alexander Hamilton Custom House One Bowling Green, Room 534 New York, NY 10004-1408 (212) 510-0500 |
| |
Claims and Noticing Agent Kroll Restructuring Administration LLC Claims Agent
(Formerly Prime Clerk LLC) 55 East 52nd Street 17th Floor www.kroll.com New York, NY 10055 (212) 257-5450 |
| Date Filed | # | Docket Text |
|---|---|---|
| 12/29/2023 | 18 | Notice of Withdrawal of Notice of Appearance (related document(s)17) filed by Sean P Williams on behalf of Ford Motor Credit Company, LLC. (Williams, Sean) (Entered: 12/29/2023) |
| 12/28/2023 | 17 | Notice of Appearance filed by Sean P Williams on behalf of Ford Motor Credit Company, LLC. (Williams, Sean) (Entered: 12/28/2023) |
| 04/26/2023 | Receipt of Amended Schedules( 22-22546-jlg) [misc,schaja] ( 32.00) Filing Fee. Receipt number A16178940. Fee amount 32.00. (Re: Doc # 16) (U.S. Treasury) (Entered: 04/26/2023) | |
| 04/26/2023 | 16 | Amended Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual (Attachments: Notice of Filing and Global Notes) Filed by Kyle J. Ortiz on behalf of Par Pharmaceutical, Inc.. (Ortiz, Kyle) (Entered: 04/26/2023) |
| 03/03/2023 | 15 | Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 Filed by Paul D. Leake on behalf of Par Pharmaceutical, Inc.. (Leake, Paul) (Entered: 03/03/2023) |
| 02/28/2023 | Pending Deadlines Terminated. (Rodriguez, Willie). (Entered: 02/28/2023) | |
| 02/27/2023 | Pending Deadlines Terminated: Schedules (Rodriguez, Willie). (Entered: 02/27/2023) | |
| 11/17/2022 | 14 | Order signed on 11/16/2022 Granting Motion To Extend Deadline to File Schedules or Provide Required Information: DEADLINE: 11/30/2022 (Related Doc # 11) (Rodriguez, Willie) (Entered: 11/17/2022) |
| 11/10/2022 | 13 | Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Par Pharmaceutical, Inc. Filed by Kyle J. Ortiz on behalf of Par Pharmaceutical, Inc.. (Ortiz, Kyle) (Entered: 11/10/2022) |
| 11/10/2022 | 12 | Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes, Summary and Schedules of Assets and Liabilities for Par Pharmaceutical, Inc. Filed by Kyle J. Ortiz on behalf of Par Pharmaceutical, Inc.. (Ortiz, Kyle) (Entered: 11/10/2022) |